Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Albumin in Heart Failure (DIORASIS)
NCT06630923Phase 3Recruiting
- Sponsor
- Democritus University of Thrace
- Start
- Jan 2023
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of albumin (human) in heart failure (HF) (2 arms), sponsored by Democritus University of Thrace. Primary endpoints: Assessment of symptoms at 72 hours and Change in the serum creatinine level at 72 hours. Started Jan 2023; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06630923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06630923.